跳至主要内容
临床试验/NCT05172986
NCT05172986已完成不适用

Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAAC

Elsan2 个研究点 分布在 1 个国家目标入组 135 人开始时间: 2021年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
135
试验地点
2
主要终点
postoperative stay of RAAC-type treatment

研究概览

简要总结

There are few published data on the benefit of Enhanced recovery program in radical prostatectomy in the management of localized prostate cancer. All the studies available on the subject are retrospective (1-3).

This randomized comparative study is proposed in order to compare in a homogeneous population (place and time) the interest of RAAC specifically in this surgery.

详细描述

The implementation of RAAC programs in healthcare establishments would improve the quality and safety of patient care (functional development and rapid convalescence of patients and reduction in postoperative morbidity through active prevention of perioperative complications) and optimization of care costs for health establishments and for health insurance (reduction in length of stay and convalescence, reduction in postoperative complications). Its implementation requires a strong involvement of all the teams and a transversal and multidisciplinary coordination, specifically dedicated to one type of intervention. This approach must therefore show its effectiveness by specialty and then by pathology within the same specialty.

There are few published data on the benefit of RAAC in radical prostatectomy in the management of localized prostate cancer. All the studies available on the subject are retrospective (1-3).

This randomized comparative study is proposed in order to compare in a homogeneous population (place and time) the interest of RAAC specifically in this surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Male over 40 and under 75
  • Patient scheduled for a robot assisted radical prostatectomy within the center
  • Affiliation to a social security scheme or beneficiary of such a scheme
  • Patient having signed the free and informed consent

排除标准

  • Minor, age ≤ 40 years or ≥ 75 years
  • ASA 4 or more
  • Severe or poorly balanced associated conditions
  • Covid + declared in the previous 3 months
  • Refusal to participate in the study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

结局指标

主要结局

postoperative stay of RAAC-type treatment

时间窗: 5 days

To assess the length of postoperative stay of RAAC-type treatment compared to standard treatment, during a robotic-assisted radical prostatectomy.

次要结局

未报告次要终点

研究者

发起方
Elsan
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验